SuperworthIntegra Lifesciences EPS IART
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Sep 30, 2026
- $0.17
- Latest quarter, Q3 FY26
- $0.19
- Fiscal year 2025
- −$6.73
Integra Lifesciences' earnings per share was $0.17 over the twelve months to Sep 30, 2026.
In its latest quarter, Q3 FY26, it was $0.19.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$6.73 | n/a |
| FY2024 | −$0.09 | −111% |
| FY2023 | $0.83 | −62% |
| FY2022 | $2.16 | +9% |
| FY2021 | $1.98 | +25% |
| FY2020 | $1.58 | +172% |
| FY2019 | $0.58 | −19% |
| FY2018 | $0.72 | −12% |
| FY2017 | $0.82 | −13% |
| FY2016 | $0.94 | n/a |
| FY2015 | −$0.06 | −112% |
| FY2014 | $0.52 | n/a |
| FY2013 | −$0.40 | −156% |
| FY2012 | $0.72 | +52% |
| FY2011 | $0.47 | −56% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY26 | $0.19 | n/a | $0.17 | |
| Q2 FY26 | $0.06 | n/a | −$0.09 | |
| Q1 FY26 | −$0.06 | n/a | −$6.46 | |
| Q4 FY25 | −$0.02 | −108% | −$6.73 | |
| Q3 FY25 | −$0.07 | n/a | −$6.46 | |
| Q2 FY25 | −$6.31 | n/a | −$6.53 | |
| Q1 FY25 | −$0.33 | n/a | −$0.38 | |
| Q4 FY24 | $0.25 | +0% | −$0.09 | |
| Q3 FY24 | −$0.14 | −158% | −$0.09 | |
| Q2 FY24 | −$0.16 | −420% | $0.29 | |
| Q1 FY24 | −$0.04 | −114% | $0.50 | |
| Q4 FY23 | $0.25 | −60% | $0.83 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Integra Lifesciences' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| IARTIntegra Lifesciences | −$0.09 | |
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| MOVMovado | $1.80 | +137% a year |
| BVSBioventus | $0.77 | |
| CDRECadre | $0.81 | −14% a year |
| EYENational Vision | $0.61 | |
| MDXGMimedx | $0.04 | −81% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| INSPInspire Medical Systems | $4.62 | +166% a year |
| Peer median | $0.94 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Integra Lifesciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.